Iberogast Balance

Bitter Candytuft Fresh Plant Extract, Matricaria Liquid Extract, Menthae Piperitae Folium, Melissae, the active ingredient in Iberogast Balance, is a herbal preparation presented as an oral liquid for oral use. It is intended for adults with functional dyspepsia, irritable bowel syndrome and other gastrointestinal discomfort. GNH USA supplies Iberogast Balance as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide.

Iberogast Balance is used to manage functional gastrointestinal disorders.

Functional dyspepsia: reduces upper abdominal discomfort, bloating and early satiety. Irritable bowel syndrome: alleviates abdominal pain, cramping and irregular bowel habits. Gastrointestinal discomfort: improves overall digestive comfort and lessens spasms.

Iberogast Balance is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Mild nausea or upset stomach - Transient abdominal discomfort - Bitter after‑taste - Flatulence or mild diarrhea - Headache - Dizziness

Serious or Rare Side Effects: - Allergic reactions such as rash, itching or angioedema - Severe hypersensitivity including anaphylaxis - Hepatic enzyme elevation or liver injury - Persistent vomiting or severe abdominal pain

Before using Iberogast Balance, consider the following precautions. - Known hypersensitivity: avoid if you have a documented allergy to any of the plant extracts. - Liver disease: use with caution and monitor liver function if pre‑existing hepatic conditions exist. - Pregnancy and breastfeeding: consult a healthcare professional before use. - Concomitant GI agents: discuss with a prescriber when using other spasmolytics or pro‑kinetics. - Pediatric use: not recommended for children without medical advice. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Iberogast Balance may interact with certain medicines; review the following categories.

Major Interactions (Avoid): - Anticoagulants or antiplatelet drugs: increased risk of bleeding. - Other strong pro‑kinetic agents: potential for excessive gastrointestinal motility.

Moderate Interactions (Monitor Closely): - Sedatives or CNS depressants: possible additive drowsiness. - Other herbal or dietary supplements affecting CYP450 enzymes: monitor for altered drug levels. - Acid‑suppressing agents: may modify absorption of some concomitant oral medications.